Stock Events

Stock Events

Change Agents 

$2.76
52
-$0.09-3.23% 13:22 Today

Statistics

Day High
0.1448
Day Low
0.1434
52W High
2.9
52W Low
0.123
Volume
31,874
Avg. Volume
-
Mkt Cap
56.89M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is a biopharmaceutical company that competes in the development of cellular and gene therapies, similar to Avalon GloboCare's focus on cell-based technologies.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that has significant investments in cell and gene therapies, making it a direct competitor in the biotech and healthcare space where Avalon operates.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is involved in the discovery, development, and delivery of innovative medicines, including cell therapy products, competing in the same therapeutic areas as Avalon.
AMGEN
AMGN
Mkt Cap233.78B
Amgen focuses on human therapeutics, including cellular and molecular biology, which aligns with Avalon's research and development in cell-based treatment options.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global biopharmaceutical company with a broad range of healthcare products, including investments in gene therapy, competing with Avalon in the innovative treatment market.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
CRISPR Therapeutics is centered on developing gene-based medicines, making it a competitor in the gene editing and therapy space where Avalon is also aiming to make an impact.
Alnylam Pharmaceuticals
ALNY
Mkt Cap31.73B
Alnylam Pharmaceuticals is pioneering RNAi therapeutics, competing with Avalon's focus on novel, cell-based therapies for treating diseases.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals is known for its work in treating cystic fibrosis and other serious diseases, competing with Avalon through its innovative approach to therapy, including gene editing and cell therapy.

About

Change Agents Corp is an artificial intelligence software company focused on developing agentic AI applications designed to help small businesses, brands, and content creators increase revenue, improve digital discoverability, and automate content creation. The company's current portfolio includes Beacon, an AI Search Optimization platform, and Catch-Up, an autonomous AI-powered content creation platform. Through its scalable Software-as-a-Service (SaaS) business model, it is focused on delivering AI solutions that create measurable customer value while generating recurring subscription revenue and long-term shareholder returns.
Show more...
CEO
Meng Li
Employees
2
Country
United States
ISIN
US05344R3021
WKN
000A3D4QG

Listings

XNAS
US
CHGA
BOATS
BOATS
ALBT.BOATS

0 Comments

Share your thoughts

FAQ

What is Change Agents stock price today?▼
The current price of CHGA is $2.76 USD — it has decreased by -3.23% in the past 24 hours. Watch Change Agents stock price performance more closely on the chart.
What is Change Agents stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Change Agents stocks are traded under the ticker CHGA.
What is Change Agents market cap?▼
Today Change Agents has the market capitalization of 56.89M
How many employees does Change Agents have?▼
As of August 31, 2026, the company has 2 employees.
In which sector is Change Agents located?▼
Change Agents operates in the Technology sector.
When did Change Agents complete a stock split?▼
The last stock split for Change Agents was on August 31, 2026 with a ratio of 1:20.
Where is Change Agents headquartered?▼
Change Agents is headquartered in FREEHOLD, United States.